Teligent Inc

NASDAQ:TLGT   2:03:12 PM EDT
0.39
-0.01 (-1.40%)
Products

FDA Says Teligent Pharma, Inc.’S Issues Voluntary Recall Of Lidocaine Hcl Topical Solution 4% (Lot # 14218, Exp. 09/2022) Due To Super Potency

Published: 08/30/2021 16:48 GMT
Teligent Inc (TLGT) - Teligent Pharma, Inc.’s Issues Voluntary Recall of Lidocaine Hcl Topical Solution 4% (lot # 14218, Exp.
09/2022) Due to Super Potency.
FDA Says to Date, Teligent Pharma, Has Not Received Any Reports of Adverse Events Related to Recall.
((reuters.
Briefs@thomsonreuters.
Com;)).